We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WHL:JSEWoolworths Holdings Limited Analysis

Data as of 2026-06-14 - not real-time

ZAC 5,170.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Woolworths Holdings Ltd trades at ZAc 5,170, modestly above its DCF‑derived fair value of ZAc 5,095, suggesting a slight premium despite a healthy upside/downside metric of ~16%. Technical indicators show a bearish trend direction, with the price sitting between the 50‑day (5,093) and 200‑day (5,342) SMAs, a negative MACD line but a bullish histogram (+27) and a neutral‑high RSI (59.8). The stock offers an attractive dividend yield of 4.56% but the payout ratio is near 98%, raising concerns about dividend sustainability. Fundamentally, revenue grew 5.2% YoY and forward EPS forecasts (3.98) imply strong earnings growth, yet the balance sheet is leveraged (debt‑to‑equity ≈ 197) and the company’s beta is low (0.16) indicating limited market sensitivity. Volatility over the past 30 days is elevated at ~21% and volume trends are decreasing, pointing to potential liquidity pressure. Geographic diversification across South Africa, Australia, New Zealand and sub‑Saharan markets adds both growth opportunities and medium‑level geographic and currency risk.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price marginally above DCF fair value
  • Bearish technical trend and decreasing volume
  • High dividend payout ratio

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Solid earnings growth outlook (forward EPS)
  • Stable dividend yield despite sustainability concerns
  • Moderate leverage with improving cash flow

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Consistent revenue growth and expanding geographic footprint
  • Potential for valuation re‑alignment as market absorbs premium
  • Strong brand positioning in consumer‑cyclical sector

Key Metrics & Analysis

Financial Health

Revenue Growth5.20%
Profit Margin2.11%
P/E Ratio26.9
ROE15.71%
ROA7.45%
Debt/Equity196.78
P/B Ratio4.4
Op. Cash FlowZAC6.5B
Free Cash FlowZAC3.7B

Technical Analysis

TrendBearish
RSI59.8
SupportZAC 4,735.00
ResistanceZAC 5,246.00
MA 20ZAC 5,005.40
MA 50ZAC 5,092.92
MA 200ZAC 5,341.52
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair ValueZAC 5,095.13
Target PriceZAC 5,995.00
Upside/Downside15.96%
GradeOvervalued
TypeGrowth
Dividend Yield4.56%

Risk Assessment

Beta0.16
Volatility20.92%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.